文献速递前列腺增生与排尿功能障碍男科与性医学

人工尿道括约肌植入术的多中心前瞻性观察研究

Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational Study.
PubMed 文献 · J Urol · 2017-08-18

该多中心前瞻性观察研究纳入2011至2014年间在5家机构接受初次AMS 800™植入的135例患者,评估围手术期并发症、免修正率及控尿与生活质量变化。结果显示植入无重大并发症,术后1、2、3年免修正率分别为94%、88%、81%,糖尿病与术前美国麻醉医师协会体能状态差是修正手术的显著危险因素,控尿与生活质量术后显著改善,但术后12个月较术后1个月出现轻微但显著的恶化。

要点

  • 术后1、2、3年免修正率分别为94%、88%、81%。
  • 糖尿病和术前美国麻醉医师协会体能状态差是修正手术的显著危险因素。
  • 控尿与生活质量术后显著改善,但术后12个月较术后1个月轻微显著恶化。

核心结论

  • 人工尿道括约肌植入术安全且持久,术后短期内显著改善患者控尿状态与生活质量。
  • 患者术后相对早期(1年内)即开始出现轻微但可察觉的控尿状态与生活质量恶化,该发现可能有助于对接受人工尿道括约肌植入术的患者进行适当咨询。

研究设计与样本

  • 多中心、前瞻性、观察性研究,纳入2011至2014年间在5家机构接受初次AMS 800™植入的135例患者。
  • 围手术期并发症按Clavien-Dindo分类进行分级。
  • 采用Cox回归分析识别修正手术的患者危险因素。
  • 术前及术后1、3、12个月采用每日尿垫数量、ICIQ-SF(国际尿失禁咨询委员会问卷简表)和KHQ(国王健康问卷)评估控尿状态与生活质量。

主要发现

  • 人工尿道括约肌植入无重大并发症。
  • 术后1、2、3年免修正率分别为94%、88%、81%。
  • 糖尿病和术前美国麻醉医师协会体能状态差是修正手术的显著危险因素。
  • 术后控尿状态与生活质量显著改善。
  • ICIQ-SF和部分KHQ条目在术后12个月较术后1个月评分出现轻微但显著的恶化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We performed a multicenter, prospective, observational study to assess outcomes, including changes in continence status and quality of life, after artificial urinary sphincter implantation. MATERIALS AND METHODS: Prospectively enrolled in this study were 135 patients who underwent primary AMS 800™ implantation between 2011 and 2014 at 1 of 5 institutions. Perioperative complications were categorized according to the Clavien-Dindo classification. We estimated the revision-free rate, that is the incidence of patients who did not undergo artificial urinary sphincter revision surgery. Cox regression analysis was performed to identify patient risk factors for revision surgery. The number of pads needed per day, ICIQ-SF (International Consultation on Incontinence Questionnaire-Short Form) and KHQ (King's Health Questionnaire) were used to estimate continence status and quality of life preoperatively, and 1, 3 and 12 months postoperatively. RESULTS: The artificial urinary sphincter was implanted without major complications. The revision-free rate 1, 2 and 3 years after implantation was 94%, 88% and 81%, respectively. Diabetes mellitus and poor preoperative American Society of Anesthesiologists® physical status were significant risk factors for revision surgery. Continence status and quality of life were markedly improved after surgery. However, ICIQ-SF and some KHQ items showed slight but significant deterioration at 12 months compared with scores 1 month after surgery. CONCLUSIONS: Artificial urinary sphincter implantation is a safe and durable procedure that substantially improves patient continence status and quality of life soon after surgery. Our results indicate that patients start to experience slight but noticeable deterioration in continence status and quality of life relatively early (within 1 year) after surgery. This finding might be helpful with appropriately counseling patients who undergo artificial urinary sphincter implantation.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Kaiho Y, Masuda H, Takei M, et al. Surgical and Patient Reported Outcomes of Artificial Urinary Sphincter Implantation: A Multicenter, Prospective, Observational Study. J Urol. 2017. PMID: 28823767. doi:10.1016/j.juro.2017.08.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。